Gary Lichtenstein - Publications, H-index & Citations

Gary Lichtenstein

university of pennsylvania

22H指数

144论文数

2.5K被引数

收录论文 12

发表时间

Efficacy and safety of upadacitinib after 4 years of treatment in patients with moderately to severely active ulcerative colitis: interim long-term data from the phase 3 open-label extension study (U-ACTIVATE)

JOURNAL OF CROHNS & COLITIS

IF8.7

2025-01-22

PREAI

Panaccione, R.; Lichtenstein, G.; Colombel, J. F.; Nakase, H.; Yao, X.; Klaff, J.; Kujawski, M.; Rizzo, L.; Suravaram, S.; Vermeire, S.

Comparative Outcomes of Laparoscopic vs Open IPAA in Patients With IBD: A Propensity Score-Matched Analysis

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2024-10-01

PREAI

Khanna, Tushar; Sehgal, Priya; Desai, Aakash; Nandish, Nilan; Tunio, Nahel; Lichtenstein, Gary

EARLY SYMPTOMATIC IMPROVEMENT WITH GUSELKUMAB INDUCTION TREATMENT IN MODERATELYTO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY 中度至重度活动性溃疡性结肠炎患者中 guselkumab 诱导治疗的早期症状改善：来自QUASAR诱导研究第3阶段的结果

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2024-06-01

PREAI

Huang, K. H. G.; Lichtenstein, G. R.; Dignass, A.; Rubin, D. T.; Yarandi, S.; Germinaro, M.; Miao, Y.; Zhang, H.; Mcgonagle, D.; Kierkus, J.; Seidler, U.; Maemoto, A.; Allegretti, J. R.; Bressler, B.; Peyrin-Biroulet, L.

An Engineering Major Does Not (Necessarily) an Engineer Make: Career Decision Making Among Undergraduate Engineering Majors

JOURNAL OF ENGINEERING EDUCATION

IF3.4

2013-01-02

102

PREAI

Lichtenstein, Gary; Loshbaugh, Heidi G.; Claar, Brittany; Chen, Helen L.; Jackson, Kristyn; Sheppard, Sheri D.

Comparing the Undergraduate Experience of Engineers to All Other Majors: Significant Differences are Programmatic

JOURNAL OF ENGINEERING EDUCATION

IF3.4

2013-01-02

PREAI

Lichtenstein, Gary; McCormick, Alexander C.; Sheppard, Sheri D.; Puma, Jini

Persistence, Engagement, and Migration in Engineering Programs

JOURNAL OF ENGINEERING EDUCATION

IF3.4

2013-01-02

364

PREAI

Ohland, Matthew W.; Sheppard, Sheri D.; Lichtenstein, Gary; Eris, Ozgur; Chachra, Debbie; Layton, Richard A.

Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2009-07-10

176

OAAI

Lichtenstein, G. R.; Diamond, R. H.; Wagner, C. L.; Fasanmade, A. A.; Olson, A. D.; Marano, C. W.; Johanns, J.; Lang, Y.; Sandborn, W. J.

Infliximab reduces colectomy in patients with moderate-to-severe ulcerative colitis: Analysis from ACT 1 and ACT 2

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2007-09-01

PREAI

Sandborn, W. J.; Rutgeerts, P.; Fengan, B. G.; Reinisch, W.; Olson, A.; Johanns, J.; Lu, J.; Rachmilewitz, D.; Hanauer, S.; Lichtenstein, G.; de Villiers, W.; Present, D.; Sands, B.; Colombel, J.

Infliximab reduces UC-related hospitalizations requiring high-dose corticosteroids

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2006-09-01

PREAI

Sandborn, W. J.; Reinisch, W.; Yan, S.; Colombel, J. F.; Lichtenstein, G. R.; Sands, B. E.; Eisenberg, D.; Xu, S.; Olson, A.; Rutgeerts, P.

The impact of increased body mass index on the clinical course of Crohn's disease

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

IF12

2006-04-01

178

PREAI